期刊文献+

美多巴联合中医辨证治疗老年帕金森病38例疗效观察 被引量:9

The therapeutic effects of madopar and TCM with differentiation of symptoms and signs on 38 old patients with Parkinson's desease
下载PDF
导出
摘要 目的观察美多巴联合中医辨证治疗老年帕金森病的疗效。方法选取76例65岁以上的帕金森病患者为研究对象,分为治疗组和对照组各38例,2组均统一接受美多巴治疗,而治疗组在美多巴治疗组基础上,根据中医辨证分型运用中药治疗,在治疗前及治疗后3个月、6个月,分别对2组使用统一帕金森评分量表(UPDRS)第Ⅲ、Ⅳ部分评分进行比较,观察中西医结合疗法在改善患者运动功能及减少并发症方面的疗效。结果治疗后3个月,治疗组与对照组UPDRSⅢ、Ⅳ评分比较差异均无统计学意义(P>0.05);治疗后6个月,治疗组与对照组UPDRSⅢ、Ⅳ评分比较差异均有统计学意义(P<0.05)。结论中西医结合治疗在改善帕金森病患者运动功能及减少并发症方面优于单纯西医治疗,但其疗效与治疗时程有关,应该坚持规范足程用药。 Objective To observe the therapeutic effect of integrated traditional Chinese medicine(TCM) and madopar on elderly patients with Parkinson' s desease.Methods Select 76 cases patients with Parkinson' s desease whose age over 65 years old for study objection,of which divided into treatment group and control group (n = 38,each).The patients in two groups patients were treated with madopar,and the treatment group also accep ted integrated traditional Chinese medicine based on differentiation of symptoms and signs for classification of syndrome. The two groups were graded and compared with branchⅢandⅣtables of unified Parkinson's disease rating scale(UPDRS) before treatment and 3 months,6 months after treatment,to observe the effect of integrated TCM and madopar for improve motor function and lessen complications.Results In theⅢandⅣbranch table of UPDRS, there was no significant difference between the two groups at 3 months after treatment(P0.05),whilet there was significant difference between the two groups at 6 months after treatment(P0.05).Conclusion The treatment of integrated TCM and western medicine could improve motor function and lessen complications,and the therapeutic effect was related to lime course of therapy.It suggested that standard and enough time course of treatment with integrated TCM and western medicine for treatmenting Parkinson' s desease.
作者 洪星
出处 《疑难病杂志》 CAS 2010年第8期563-565,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 中医辨证 帕金森病 美多巴 帕金森评分量表 Traditional Chinese medicine differentiation of symptoms and signs Parkinson's desease Madopar Unified Parkingson's disease rating scale
  • 相关文献

参考文献8

二级参考文献37

  • 1陈生弟,周孝达,徐德隆,朱承谟,张冀先,国毓智,匡琴芳,李彪.偏侧帕金森病猴模型的脑血流灌注SPECT在体显像研究[J].中华核医学杂志,1994,14(4):209-210. 被引量:14
  • 2赵澎,程焱.简明帕金森病评分量表/帕金森病致残量表评估帕金森病患者运动功能的信度和效度[J].中国临床康复,2006,10(14):56-58. 被引量:6
  • 3陈茹.帕金森病研究进展[J].中国康复理论与实践,2007,13(7):637-639. 被引量:14
  • 4王新德.帕金森病和帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 5Rabey JM,Bass H,Bonucceli U,et al.Evaluation of the short Parkinson' s Evaluation Scale:a new friendly scale for the evaluation of Parkinson' s disease in clinical drug trials[J].Clin Neuropharmmacol,1997,20(4):322-337.
  • 6Marinus J,Visser M,Satiggelbout A,et al.A short scale for the assessment of motor impairments and disabiliyy in Parkinson's disease:the SPES/SCOPA[J].J Neurol Neurosurg Psychiatry,2004,75(3):388-395.
  • 7Duncan PW,Wallace D,Lai SM,et al.The stroke impact scale version 2.0 evaluation of reliability,validity,and sensitivity to change[J].Stroke,1999,30(10):2131-2140.
  • 8Daring Y,Andren E,Nordholm L,et al.Reliability of an interview approach to the Functional Independence Measure[J].Clin Rehahil,2001,15(3):301-310.
  • 9Steffen T,Seney M.Test-retest reliability and minimal detectable change on balance and ambulation tests,the 36-item short-form health survey,and the unified Parkinson disease rating scale in people with parkinsonism[J].Phys Thor,2008,88(7):733-746.
  • 10[1]Levy G,Tang MX,Louis ED,et al.The association of incident dementia with mortality in PD[J].Neurology,2002,59(11):1 708-1 713.

共引文献1216

同被引文献78

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部